Gene Expression Profiling

Gene Expression Profiling refers to the systematic measurement of messenger RNA levels across thousands of genes simultaneously to determine patterns of gene activity within cells or tissues under specific conditions. This approach provides insights into biological states, disease mechanisms, and cellular responses by identifying genes that are upregulated or downregulated in response to stimuli, treatment, or disease progression. Technologies include microarrays and next-generation sequencing-based RNA sequencing platforms.

The biopharmaceutical industry applies gene expression profiling across discovery, development, and clinical research. Profiling supports target identification by revealing dysregulated pathways and validates drug action by confirming modulation of intended biological networks. In clinical development, expression signatures serve as pharmacodynamic biomarkers demonstrating target engagement and supporting dose selection. Oncology programmes frequently use gene expression profiling to stratify patients, predict treatment response, and identify resistance mechanisms. As bioinformatics capabilities advance, expression profiling continues enabling data-driven drug development and precision medicine strategies improving clinical success rates.